Table 5.
Variables | Outcome Status | ||||
---|---|---|---|---|---|
TB (%) | Total | IR/100PY | CHR (95% CI) | AHR (95% CI) | |
Age | |||||
18–29 | 11(7.6) | 145 | 2.67 | 0.41[0.15,1.11] | 1.41[0.43,4.64] |
30–39 | 14(9.5) | 148 | 3.39 | 0.52[0.20,1.35] | 1.83[0.66,5.09] |
40–49 | 7(11.1) | 63.0 | 4.08 | 0.62[0.21,1.80] | 1.38[0.43,4.44] |
≥50 | 6(17.1) | 35.0 | 6.81 | 1 | 1 |
Sex | |||||
Male | 18(15.7) | 115 | 6.01 | 2.29[1.21,4.33]* | 1.98[0.97,4.07] |
Female | 20(7.2) | 276 | 2.55 | 1 | 1 |
Residence | |||||
Rural | 9(16.7) | 54.0 | 6.60 | 2.10[0.99,4.44] | 1.02[0.38,2.70] |
Urban | 29(8.6) | 337 | 3.06 | 1 | 1 |
INH status | |||||
Completed | 2(1.0) | 193 | 0.35 | 0.05[0.01,0.21]* | 0.08[0.02,0.37]* |
Never on INH | 36(18.2) | 198 | 7.10 | 1 | 1 |
ART status | |||||
On ART | 8(2.4) | 336 | 0.81 | 0.03[0.01,0.07]* | 0.02[0.01,0.04]* |
Pre-ART | 30(54.5) | 55.0 | 32.04 | 1 | 1 |
B. WHO stage | |||||
Stage I and II | 5(2.3) | 215 | 0.78 | 0.11[0.04,0.29]* | 0.22[0.08,0.62]* |
Stage III and IV | 33(18.8) | 176 | 7.42 | 1 | 1 |
B. Functional | |||||
Ambula. & Be. | 15(19.0) | 78.0 | 7.61 | 2.79[1.46,5.35]* | 0.95[0.43,2.10] |
Working | 23(7.4) | 312 | 2.59 | 1 | 1 |
Baseline BMI | |||||
<18.5 kg/m2 | 23(15.2) | 151 | 5.79 | 2.56[1.34,4.91]* | 1.90[0.24,15.21] |
≥18.5 kg/m2 | 15(6.3) | 238 | 2.18 | 1 | |
BMI at start S. | |||||
<18.5 kg/m2 | 22(19) | 116 | 7.52 | 3.53[1.86,6.73]* | 0.73[0.36,1.48] |
≥18.5 kg/m2 | 16(5.8) | 275 | 2.02 | 1 | 1 |
Baseline CD4 | |||||
≤350 cells/μL | 31(10.9) | 284 | 4.02 | 1.76[0.78,7.24] | 3.76[1.39,10.18]* |
>350 cells/μL | 7(6.5) | 107 | 2.24 | 1 | 1 |
Duration of HI. | |||||
<5 years | 37(14.9) | 249 | 5.60 | 22.8[3.12,165.9]* | 1.82[0.16,20.75] |
≥5 years | 1(0.7) | 142 | 0.24 | 1 | 1 |
Notes: *Statistically significant at P-value≤0.05 or one not included in CI, confidence interval; inf, infection; B. hemoglobin, baseline hemoglobin; B. functional status, baseline functional status; CHR, crude hazard ratio; AHR, adjusted hazard ratio; IR, incidence rate; PY, person years; ab, above; Dx, diagnosis; o & b, only and both; duration of HI, duration of HIV diagnosis, ART initi- initiation.